Moreover, the lower the expression of GZMB as a protective factor (Figure 7C), the worse the prognosis was; thus, TRIM52-AS1 may be concluded to promote the progression of cervical cancer through miR-378a/GZMB, which needs to be studied further for validation. Here, TRIM52 is linked to cervical cancer.